India Clears Wockhardt, Biocon To Increase Insulin-Drug Prices
This article was originally published in PharmAsia News
Executive Summary
India's regulator of drug prices cleared two pharmaceutical companies to increase prices by 18% for insulin drugs for treating diabetes